Evidence map›Paper›PMID 35968218›Full record

ArticleTherapeutic advances in chronic disease2022

Granulomatous hepatitis in a Saudi child with

Meshari A Alaifan, Ohood Abusharifah, Rana Yagoub Bokhary, Babajan Banaganapalli, Noor Ahmad Shaik, Naglaa M Kamal, Omar I Saadah

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Therapeutic advances in chronic disease, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact, top 87% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Meshari A AlaifanDepartment of Pediatrics, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.ORCID https://orcid.org/0000-0002-0540-8430
Ohood AbusharifahDepartment of Pediatrics, Maternity and Children Hospital Abha, Abha, Saudi Arabia.ORCID https://orcid.org/0000-0003-0665-901X
Rana Yagoub BokharyDepartment of Pathology, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.
Babajan BanaganapalliPrincess Al-Jawhara Center of Excellence in Research of Hereditary Disorders, King Abdulaziz University, Jeddah, Saudi Arabia.
Noor Ahmad ShaikPrincess Al-Jawhara Center of Excellence in Research of Hereditary Disorders, King Abdulaziz University, Jeddah, Saudi Arabia.
Naglaa M KamalDepartment of Pediatrics, Kasr Alainy Faculty of Medicine, Cairo University, Cairo, Egypt.ORCID https://orcid.org/0000-0002-8535-3838
Omar I SaadahDepartment of Pediatrics, Faculty of Medicine, King Abdulaziz University, P.O. Box 80205, Jeddah 21589, Saudi Arabia.ORCID https://orcid.org/0000-0002-3744-9907
King Abdulaziz University · SACairo University · EGMaternity and Children's Hospital · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Interleukin-2 receptor alpha (

Indexed as

CD25granulomahepatitisIL2RAimmune diseaseimmunodeficiency

Identifiers

PMID35968218
PMCPMC9373126
OpenAlexW4298839770

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.